In recent years, new issues related to quality assurance for pharmaceutical products have arisen. These issues have generally resulted from the progressive globalization of the pharmaceutical industry. Supply chains have been growing wider in scope. Data integrity deficiencies have ballooned around the world, resulting in US and European regulatory guidances. And the introduction of technical innovations, such as continuous manufacturing, has made new approaches to manufacturing and quality control a necessity. In light of these circumstances, PDA’s Japan Chapter hosted its 23^rd annual meeting with the theme: “New Trends in Quality Assurance,” Nov. 29–30, in Tokyo.